CY2106B1 - Topical ketoconazole compositions - Google Patents

Topical ketoconazole compositions

Info

Publication number
CY2106B1
CY2106B1 CY9800008A CY9800008A CY2106B1 CY 2106 B1 CY2106 B1 CY 2106B1 CY 9800008 A CY9800008 A CY 9800008A CY 9800008 A CY9800008 A CY 9800008A CY 2106 B1 CY2106 B1 CY 2106B1
Authority
CY
Cyprus
Prior art keywords
pct
sec
date
topical
compositions
Prior art date
Application number
CY9800008A
Other languages
English (en)
Inventor
Marc Karel Josef Francois
Alfons Jeanne Wouters
Gerard Frans Maria Cauwenbergh
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CY2106B1 publication Critical patent/CY2106B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
CY9800008A 1993-01-21 1998-06-16 Topical ketoconazole compositions CY2106B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93200145 1993-01-21

Publications (1)

Publication Number Publication Date
CY2106B1 true CY2106B1 (en) 2002-04-26

Family

ID=8213579

Family Applications (1)

Application Number Title Priority Date Filing Date
CY9800008A CY2106B1 (en) 1993-01-21 1998-06-16 Topical ketoconazole compositions

Country Status (18)

Country Link
US (1) US5654293A (de)
EP (1) EP0680328B1 (de)
JP (1) JP3918119B2 (de)
KR (1) KR100300525B1 (de)
CN (1) CN1096860C (de)
AT (1) ATE146965T1 (de)
AU (1) AU683865B2 (de)
CA (1) CA2153681C (de)
CY (1) CY2106B1 (de)
DE (1) DE69401336T2 (de)
DK (1) DK0680328T3 (de)
ES (1) ES2098921T3 (de)
FI (1) FI114009B (de)
GR (1) GR3022212T3 (de)
HU (1) HU221319B1 (de)
NZ (1) NZ259866A (de)
RU (1) RU2126256C1 (de)
WO (1) WO1994016710A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2721212B1 (fr) * 1994-06-17 1996-09-13 Pf Medicament Composition et procédé d'obtention d'une émulsion de désonide.
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
FR2747568B1 (fr) * 1996-04-17 1999-09-17 Oreal Utilisation d'au moins un inhibiteur de lipoxygenase et d'au moins un inhibiteur de cyclo-oxygenase pour modifier la pousse des poils et/ou des cheveux
EP0872229A1 (de) 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Mittel enthaltend ein Fungizid und ein Phospholipid
TR200001117T2 (tr) * 1997-10-22 2000-09-21 Ponikau Jens Mukozal dokudaki enflomasyonu önlemek ve tedavi etmek için maddeler ve yöntemler.
US6238683B1 (en) 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
GB9915625D0 (en) 1999-07-02 1999-09-01 Cortendo Ab Method
SE9902675D0 (sv) * 1999-07-12 1999-07-12 Astra Ab Pharmaceutical formulations, doses & regimens
GB2365770B (en) * 2000-08-18 2002-07-31 Diomed Dev Ltd Antifungal ketoconazole composition for topical use
RU2197247C2 (ru) * 2001-02-26 2003-01-27 Закрытое акционерное общество "ФАРМАЦЕВТИЧЕСКАЯ ФИРМА "ДАРНИЦА" Средство для лечения дерматологических заболеваний
RU2215529C1 (ru) * 2002-05-24 2003-11-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противогрибковый фармацевтический состав и способ его получения
CA2528776A1 (en) * 2002-10-24 2004-05-06 G & R Pharmaceuticals, Llc Antifungal formulations
DE102004014617A1 (de) * 2004-03-22 2005-10-13 Beiersdorf Ag Kosmetisches Produkt, umfassend eine thixotropiearme Öl-in-Wasser-Emulsion und einen transparenten Behälter
MXPA06013168A (es) * 2004-05-13 2007-05-15 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
DE102004032837A1 (de) * 2004-07-02 2006-02-09 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus einem oder mehreren Biochinonen und einem oder mehreren Isoflavonen zur Verbesserung der Hautkonturen
CN100418530C (zh) * 2005-04-06 2008-09-17 河南省眼科研究所 一种酮康唑滴眼液及其制造方法
RU2337689C1 (ru) * 2007-04-18 2008-11-10 Общество с ограниченной ответственностью "Фармацевтические технологии" Средство для лечения поверхностных микозов
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
BR112013033239A2 (pt) 2011-06-22 2016-09-06 Vyome Biosciences pró-farmácos de conjugado baseado em atifungicos e antibacterianos
US9029342B2 (en) 2012-09-17 2015-05-12 Board Of Regents Of The University Of Texas System Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
BE1022727B1 (nl) * 2015-04-20 2016-08-24 Stasisport Pharma Nv Fusidinezuur crème en methode voor het maken hiervan
CN107260656B (zh) * 2016-04-08 2021-02-09 湖北人福成田药业有限公司 地奈德乳膏及其制备方法
WO2018144841A1 (en) * 2017-02-03 2018-08-09 Board Of Regents, The University Of Texas System Topical voriconazole for the treatment of pain
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンb3化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
CA2103351C (en) * 1991-04-11 2000-01-25 Drore Eisen Method of treatment using steroid mouthwash

Also Published As

Publication number Publication date
HK1005999A1 (en) 1999-02-05
AU5883394A (en) 1994-08-15
NZ259866A (en) 1999-07-29
JP3918119B2 (ja) 2007-05-23
CN1116824A (zh) 1996-02-14
RU2126256C1 (ru) 1999-02-20
CN1096860C (zh) 2002-12-25
DE69401336T2 (de) 1997-04-24
DE69401336D1 (de) 1997-02-13
GR3022212T3 (en) 1997-04-30
EP0680328A1 (de) 1995-11-08
WO1994016710A1 (en) 1994-08-04
ES2098921T3 (es) 1997-05-01
FI953505L (fi) 1995-07-20
DK0680328T3 (da) 1997-01-20
FI114009B (fi) 2004-07-30
HU221319B1 (en) 2002-09-28
AU683865B2 (en) 1997-11-27
CA2153681A1 (en) 1994-08-04
EP0680328B1 (de) 1997-01-02
CA2153681C (en) 2004-05-25
US5654293A (en) 1997-08-05
HU9501959D0 (en) 1995-09-28
FI953505A0 (fi) 1995-07-20
JPH08505861A (ja) 1996-06-25
KR100300525B1 (ko) 2001-10-22
ATE146965T1 (de) 1997-01-15
HUT73233A (en) 1996-07-29

Similar Documents

Publication Publication Date Title
CY2106B1 (en) Topical ketoconazole compositions
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
GR3022510T3 (en) Lyospheres comprising gonadotropin
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
TW263499B (de)
TW261513B (de)
IL115105A (en) Topical ketoconazole emulsions lacking sodium sulfite
TW252971B (de)
DE69302677D1 (de) Liposomale piroxycam formulierung
DE69703796D1 (de) N-bis- oder n-tris-[(1,2-dicarboxy-ethoxy)-ethyl]-amin-derivate und herstellung und anwendung derselben
DK0751764T3 (da) Præparat indeholdende retinal
GR3023677T3 (en) Neutral auto-gloss emulsion for the maintenance of floors (iii).
AU5816396A (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
AU691738B2 (en) Process for preparing spirolaxine and spirolaxine methyl ether
UA70975C2 (uk) Похідні 1,4-діарил-2-фтор-1-бутен-3-олу, спосіб їх одержання та способи одержання похідних 1,4-діарил-2-фтор-1,3-бутадієну і 1,4-діарил-2-фтор-2-бутену
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them